Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KARSTEN BO JENSEN ApS, HOVSMED.dk

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1%   Bankruptcy risk   1.0% 1.2% 1.1% 1.1% 1.0% 0.9% 13.3% 13.1%   Credit score (0-100)   89 83 83 83 87 86 17 18   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   125.1 57.4 72.2 77.1 124.5 167.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,337 1,989 1,897 2,088 2,394 2,343 0.0 0.0   EBITDA   381 377 390 346 544 575 0.0 0.0   EBIT   267 261 310 258 449 446 0.0 0.0   Pre-tax profit (PTP)   276.0 252.3 338.3 191.0 445.1 495.5 0.0 0.0   Net earnings   221.2 187.5 274.0 153.6 341.4 418.0 0.0 0.0   Pre-tax profit without non-rec. items   276 252 338 191 445 495 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   328 211 307 350 255 610 0.0 0.0   Shareholders equity total   1,159 1,072 1,071 975 1,116 1,334 884 884   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,772 1,602 1,669 1,488 1,702 1,971 884 884   Net Debt   -1,148 -1,172 -1,041 -875 -1,148 -1,119 -884 -884     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,337 1,989 1,897 2,088 2,394 2,343 0.0 0.0   Gross profit growth   2.2% -14.9% -4.6% 10.1% 14.6% -2.1% -100.0% 0.0%   Employees   0 0 4 4 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,772 1,602 1,669 1,488 1,702 1,971 884 884   Balance sheet change%   -4.0% -9.6% 4.2% -10.8% 14.4% 15.8% -55.2% 0.0%   Added value   380.8 377.4 389.9 346.4 538.2 575.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -57 -234 15 -46 -190 225 -610 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.4% 13.1% 16.3% 12.3% 18.8% 19.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.9% 16.5% 21.5% 17.8% 28.5% 27.5% 0.0% 0.0%   ROI %   24.1% 25.0% 32.9% 27.5% 43.5% 41.2% 0.0% 0.0%   ROE %   18.6% 16.8% 25.6% 15.0% 32.7% 34.1% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   65.4% 66.9% 64.2% 65.5% 65.6% 67.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -301.5% -310.5% -267.0% -252.7% -210.9% -194.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   2.4 2.8 2.4 2.2 2.8 2.3 0.0 0.0   Current Ratio   2.5 2.8 2.5 2.3 2.9 2.4 0.0 0.0   Cash and cash equivalent   1,148.4 1,171.8 1,040.8 875.3 1,147.6 1,119.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   451.0 484.5 357.4 272.0 547.9 329.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 97 87 135 144 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 97 87 136 144 0 0   EBIT / employee   0 0 77 64 112 112 0 0   Net earnings / employee   0 0 68 38 85 104 0 0